Universal Cells
Timothy Turkalo is a Scientist II at Universal Cells since April 2021. Prior to this role, Timothy was a Scientist I at the same company. Before joining Universal Cells, Timothy was a PHD Candidate at the University of California, Berkeley, where Timothy received their Doctor of Philosophy degree in Cell/Cellular and Molecular Biology in August 2020.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.